The role of an in-house audit group as an innovative tool to review clinical trials
Crossref DOI link: https://doi.org/10.1186/1745-6215-16-S2-O50
Published Online: 2015-11-16
Published Print: 2015-12
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Trivedi, Shivali
Hathi, Krishna
Aslam, Natasha
Saleem, Nausheen
Gyertson, Kylie
Whelan, Jeremy
License valid from 2015-11-16